Jazz Pharmaceuticals
JAZZ
JAZZ
498 hedge funds and large institutions have $7.11B invested in Jazz Pharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 164 increasing their positions, 179 reducing their positions, and 58 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
3% less capital invested
Capital invested by funds: $7.32B → $7.11B (-$203M)
8% less repeat investments, than reductions
Existing positions increased: 164 | Existing positions reduced: 179
Holders
498
Holding in Top 10
6
Calls
$41M
Puts
$33.5M
Top Buyers
| 1 | +$92.6M | |
| 2 | +$84.2M | |
| 3 | +$80.6M | |
| 4 |
AC
Armistice Capital
New York
|
+$42.3M |
| 5 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$28.1M |
Top Sellers
| 1 | -$136M | |
| 2 | -$91.9M | |
| 3 | -$48.5M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$38.5M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$38.5M |